Breast Cancer Research

official impact factor 5.79

Open Access Highly Access Email this article to a friend

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Vasso Apostolopoulos*, Geoffrey A Pietersz, Anastasios Tsibanis, Annivas Tsikkinis, Heleni Drakaki, Bruce E Loveland, Sara J Piddlesden, Magdalena Plebanski, Dodie S Pouniotis, Michael N Alexis, Ian F McKenzie and Stamatis Vassilaros

Breast Cancer Research 2006, 8:R27 doi:10.1186/bcr1505

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.